176 related articles for article (PubMed ID: 2494376)
1. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
Schädlich HR; Büchler M; Beger HG
Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
[TBL] [Abstract][Full Text] [Related]
2. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
Hesse B; Lankisch PG; Kunze H
Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
Freise J; Wittenberg H; Magerstedt P
Klin Wochenschr; 1989 Feb; 67(3):149-52. PubMed ID: 2467043
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
Freise J; Magerstedt P; Schmid K
Enzyme; 1983; 30(3):209-12. PubMed ID: 6194983
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
Nishijima J; Okamoto M; Nakaguchi K; Ogawa M; Yamano T; Mori T
Gen Pharmacol; 1985; 16(3):177-82. PubMed ID: 3926598
[TBL] [Abstract][Full Text] [Related]
6. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
Freise J; Schmidt FW; Magerstedt P; Schmid K
Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
[TBL] [Abstract][Full Text] [Related]
7. Influence of aprotinin and gabexate mesilate on arachidonic acid release by the Ca-ionophore A 23187 in the lung.
Seeger W; Wolf H; Graubert E; Moser U; Neuhof H; Roka L
Adv Exp Med Biol; 1983; 156():553-67. PubMed ID: 6190378
[TBL] [Abstract][Full Text] [Related]
8. [Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept].
Kahle M; Klein U; König W; Martin U; Alles JU
Z Gastroenterol; 1985 Dec; 23(12):687-93. PubMed ID: 3937346
[TBL] [Abstract][Full Text] [Related]
9. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
[TBL] [Abstract][Full Text] [Related]
10. Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis.
Kahle M; König H; Filler RD
Klin Wochenschr; 1989 Feb; 67(3):177-9. PubMed ID: 2494378
[TBL] [Abstract][Full Text] [Related]
11. Effects of the anti-inflammatory serine esterase inhibitor, FOY, on phospholipase A2 (EC 3.1.1.4) activity in rabbit polymorphonuclear leukocytes.
Kunze H; Bohn E; Damerau B
Pharmacol Res Commun; 1983 Oct; 15(9):869-78. PubMed ID: 6417683
[TBL] [Abstract][Full Text] [Related]
12. Regeneration of full enzymatic activity by reoxidation of reduced pancreatic phospholipase A2.
van Scharrenburg GJ; de Haas GH; Slotboom AJ
Hoppe Seylers Z Physiol Chem; 1980 Apr; 361(4):571-6. PubMed ID: 7189740
[TBL] [Abstract][Full Text] [Related]
13. Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice.
Caronna R; Diana L; Nofroni I; Sibio S; Catinelli S; Sammartino P; Chirletti P
Dig Dis Sci; 2005 May; 50(5):868-73. PubMed ID: 15906759
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
Davidson FF; Dennis EA; Powell M; Glenney JR
J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
Freise J
Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
[TBL] [Abstract][Full Text] [Related]
16. Competitive inhibition of lipolytic enzymes. III. Some acylamino analogues of phospholipids are potent competitive inhibitors of porcine pancreatic phospholipase A2.
de Haas GH; Dijkman R; van Oort MG; Verger R
Biochim Biophys Acta; 1990 Mar; 1043(1):75-82. PubMed ID: 2310763
[TBL] [Abstract][Full Text] [Related]
17. Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent.
Aarsman AJ; Mynbeek G; van den Bosch H; Rothhut B; Prieur B; Comera C; Jordan L; Russo-Marie F
FEBS Lett; 1987 Jul; 219(1):176-80. PubMed ID: 2954856
[TBL] [Abstract][Full Text] [Related]
18. Reaction of Woodward's Reagent K with pancreatic porcine phospholipase A2: modification of an essential carboxylase residue.
Dinur D; Kantrowitz ER; Hajdu J
Biochem Biophys Res Commun; 1981 May; 100(2):785-92. PubMed ID: 7271782
[No Abstract] [Full Text] [Related]
19. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
[TBL] [Abstract][Full Text] [Related]
20. Structural importance of the amino-terminal residue of pancreatic phospholipase A2.
van Scharrenburg GJ; Jansen EH; Egmond MR; de Haas GH; Slotboom AJ
Biochemistry; 1984 Dec; 23(25):6285-94. PubMed ID: 6441599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
